CMAJ • September 28, 2004; 171 (7). doi:10.1503/cmaj.1040774.
© 2004 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wood, E.
Right arrow Articles by Tyndall, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wood, E.
Right arrow Articles by Tyndall, M. W.
Related Collections
Right arrow Drug misuse


Research
Recherche

Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users

Evan Wood, Thomas Kerr, Will Small, Kathy Li, David C. Marsh, Julio S.G. Montaner and Mark W. Tyndall

From the British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC (all authors); the Departments of Health Care and Epidemiology (Wood) and Medicine (Montaner, Tyndall), Faculty of Medicine, University of British Columbia, Vancouver, BC; Vancouver Coastal Health (Marsh), Vancouver, BC; and the Canadian HIV/AIDS Legal Network, Montréal, Que. (Kerr)

Background: North America's first medically supervised safer injecting facility for illicit injection drug users was opened in Vancouver on Sept. 22, 2003. Although similar facilities exist in a number of European cities and in Sydney, Australia, no standardized evaluations of their impact have been presented in the scientific literature.

Methods: Using a standardized prospective data collection protocol, we measured injection-related public order problems during the 6 weeks before and the 12 weeks after the opening of the safer injecting facility in Vancouver. We measured changes in the number of drug users injecting in public, publicly discarded syringes and injection-related litter. We used Poisson log-linear regression models to evaluate changes in these public order indicators while considering potential confounding variables such as police presence and rainfall.

Results: In stratified linear regression models, the 12-week period after the facility's opening was independently associated with reductions in the number of drug users injecting in public (p < 0.001), publicly discarded syringes (p < 0.001) and injection-related litter (p < 0.001). The predicted mean daily number of drug users injecting in public was 4.3 (95% confidence interval [CI] 3.5–5.4) during the period before the facility's opening and 2.4 (95% CI 1.9–3.0) after the opening; the corresponding predicted mean daily numbers of publicly discarded syringes were 11.5 (95% CI 10.0–13.2) and 5.4 (95% CI 4.7–6.2). Externally compiled statistics from the city of Vancouver on the number of syringes discarded in outdoor safe disposal boxes were consistent with our findings.

Interpretation: The opening of the safer injecting facility was independently associated with improvements in several measures of public order, including reduced public injection drug use and public syringe disposal.





This article has been cited by other articles:


Home page
J. Epidemiol. Community HealthHome page
K DeBeck, W Small, E Wood, K Li, J Montaner, and T Kerr
Public injecting among a cohort of injecting drug users in Vancouver, Canada
J Epidemiol Community Health, January 1, 2009; 63(1): 81 - 86.
[Abstract] [Full Text] [PDF]


Home page
AJPHHome page
L. Beletsky, C. S. Davis, E. Anderson, and S. Burris
The Law (and Politics) of Safe Injection Facilities in the United States
Am J Public Health, February 1, 2008; 98(2): 231 - 237.
[Abstract] [Full Text] [PDF]


Home page
AJPHHome page
T. Kerr, M. W. Tyndall, R. Zhang, C. Lai, J. S.G. Montaner, and E. Wood
Circumstances of First Injection Among Illicit Drug Users Accessing a Medically Supervised Safer Injection Facility
Am J Public Health, July 1, 2007; 97(7): 1228 - 1230.
[Abstract] [Full Text] [PDF]


Home page
Health Educ BehavHome page
C. M. Cleland, S. Deren, C. M. Fuller, S. Blaney, J. M. McMahon, S. Tortu, D. C. Des Jarlais, and D. Vlahov
Syringe Disposal Among Injection Drug Users in Harlem and the Bronx During the New York State Expanded Syringe Access Demonstration Program
Health Educ Behav, April 1, 2007; 34(2): 390 - 403.
[Abstract] [PDF]


Home page
J Public Health (Oxf)Home page
J.-A. Stoltz, E. Wood, W. Small, K. Li, M. Tyndall, J. Montaner, and T. Kerr
Changes in injecting practices associated with the use of a medically supervised safer injection facility
J Public Health, March 1, 2007; 29(1): 35 - 39.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
E. Wood, M. W. Tyndall, J. S. Montaner, and T. Kerr
Summary of findings from the evaluation of a pilot medically supervised safer injecting facility.
Can. Med. Assoc. J., November 21, 2006; 175(11): 1399 - 1404.
[Abstract] [Full Text] [PDF]


Home page
AJPHHome page
E. Wood, M. W. Tyndall, Z. Qui, R. Zhang, J. S. G. Montaner, and T. Kerr
Service Uptake and Characteristics of Injection Drug Users Utilizing North America's First Medically Supervised Safer Injecting Facility
Am J Public Health, May 1, 2006; 96(5): 770 - 773.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
T. Kerr, J.-A. Stoltz, M. Tyndall, K. Li, R. Zhang, J. Montaner, and E. Wood
Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study
BMJ, January 28, 2006; 332(7535): 220 - 222.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
S. W. Hwang
Homelessness and harm reduction
Can. Med. Assoc. J., January 3, 2006; 174(1): 50 - 51.
[Full Text] [PDF]


Home page
Evid. Based Nurs.Home page
I. Goldstone
Marginalised HIV positive drug users felt that an HIV diagnosis created benefits as well as losses
Evid. Based Nurs., January 1, 2006; 9(1): 30 - 30.
[Full Text] [PDF]

eLetters:

Read all eLetters

Harm reduction approach and drug use
Ediriweera B.R., Desapriya
CMAJ, 30 Sep 2004 [Full text]